WHO ICTRP trial
Homoeopathic Treatment for Osteoarthritis
CTRI/2022/06/042995 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2022/06/042995 |
|---|---|
| Public title | Homoeopathic Treatment for Osteoarthritis |
| Scientific title | A synopsis on Assessment of Likelihood Ratio of four symptoms of Medorrhinum in Patients of Osteoarthritis. |
| Primary sponsor | National Institute of Homoeopathy |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: M199- Osteoarthritis, unspecified site |
| Interventions | Intervention1: Medorrhinum: Dose: As required for the patient Frequency: As per the need of patient Route of administration: Oral Total duration: 6 months |
| Registration date | Mar 6, 2022 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: